- Home
- SA vs SLNO Comparison
SA vs SLNO Comparison
Compare SA & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SA | SLNO |
|---|---|---|
| Founded | 1979 | 1999 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2004 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SA | SLNO |
|---|---|---|
| Price | $30.26 | $39.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $65.00 | ★ $102.75 |
| AVG Volume (30 Days) | 1.1M | ★ 1.7M |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $1,450,788.00 |
| Revenue This Year | N/A | $150.65 |
| Revenue Next Year | N/A | $56.10 |
| P/E Ratio | ★ N/A | $101.38 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $9.40 | $29.43 |
| 52 Week High | $40.06 | $89.12 |
Technical Indicators
Market Signals| Indicator | SA | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 51.44 | 61.47 |
| Support Level | $27.94 | $38.17 |
| Resistance Level | $31.26 | $41.48 |
| Average True Range (ATR) | 1.72 | 2.14 |
| MACD | 0.35 | 0.78 |
| Stochastic Oscillator | 77.18 | 94.46 |
Price Performance
Historical ComparisonAbout SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration and development of gold properties situated in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, the Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.